DK3609319T3 - Musemodeller og terapeutiske molekyler - Google Patents
Musemodeller og terapeutiske molekyler Download PDFInfo
- Publication number
- DK3609319T3 DK3609319T3 DK18719629.0T DK18719629T DK3609319T3 DK 3609319 T3 DK3609319 T3 DK 3609319T3 DK 18719629 T DK18719629 T DK 18719629T DK 3609319 T3 DK3609319 T3 DK 3609319T3
- Authority
- DK
- Denmark
- Prior art keywords
- mouse models
- therapeutic molecules
- therapeutic
- molecules
- models
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8518—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1705725.8A GB2561352B (en) | 2017-04-10 | 2017-04-10 | Animal models and therapeutic molecules |
| PCT/GB2018/050946 WO2018189520A1 (en) | 2017-04-10 | 2018-04-10 | Animal models and therapeutic molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3609319T3 true DK3609319T3 (da) | 2025-03-31 |
Family
ID=58744850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18719629.0T DK3609319T3 (da) | 2017-04-10 | 2018-04-10 | Musemodeller og terapeutiske molekyler |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200056202A1 (da) |
| EP (2) | EP3609319B1 (da) |
| JP (3) | JP2020512840A (da) |
| CN (1) | CN111031789A (da) |
| BR (1) | BR112019021252A2 (da) |
| CA (1) | CA3059513A1 (da) |
| DK (1) | DK3609319T3 (da) |
| ES (1) | ES3015425T3 (da) |
| FI (1) | FI3609319T3 (da) |
| GB (1) | GB2561352B (da) |
| PL (1) | PL3609319T3 (da) |
| PT (1) | PT3609319T (da) |
| WO (1) | WO2018189520A1 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2580017C2 (ru) | 2010-07-26 | 2016-04-10 | Трианни, Инк. | Трансгенные животные и способы применения |
| US10793829B2 (en) | 2010-07-26 | 2020-10-06 | Trianni, Inc. | Transgenic mammals and methods of use thereof |
| US10662256B2 (en) | 2010-07-26 | 2020-05-26 | Trianni, Inc. | Transgenic mammals and methods of use thereof |
| WO2017095939A1 (en) | 2015-12-03 | 2017-06-08 | Trianni, Inc. | Enhanced immunoglobulin diversity |
| AU2017213633B2 (en) | 2016-02-04 | 2023-08-03 | Trianni, Inc. | Enhanced production of immunoglobulins |
| GB2578867A (en) * | 2018-10-09 | 2020-06-03 | Genome Res Ltd | Animal models and therapeutic molecules |
| WO2021003149A1 (en) * | 2019-07-01 | 2021-01-07 | Trianni, Inc. | Transgenic mammals and methods of use |
| FI3993623T3 (fi) | 2019-07-01 | 2025-05-25 | Zoetis Services Llc | Muuntogeeniset jyrsijät ja niiden käyttömenetelmät |
| GB202012331D0 (en) | 2020-08-07 | 2020-09-23 | Petmedix Ltd | Therapeutic antibodies |
| GB202104943D0 (en) | 2021-04-07 | 2021-05-19 | Petmedix Ltd | A method for identifying lead sequences |
| WO2022235759A1 (en) * | 2021-05-05 | 2022-11-10 | Trianni, Inc. | Transgenic rodents expressing chimeric equine-rodent antibodies and methods of use thereof |
| CA3218564A1 (en) * | 2021-05-05 | 2022-11-10 | Leveragen, Inc. | Engineered non-human animals for producing antibodies |
| CN117651486A (zh) * | 2021-05-05 | 2024-03-05 | 利威瑞健股份有限公司 | 用于生产抗体的工程改造的非人动物 |
| GB202107372D0 (en) | 2021-05-24 | 2021-07-07 | Petmedix Ltd | Animal models and therapeutics molecules |
| JP2024526122A (ja) * | 2021-06-17 | 2024-07-17 | ペットメディックス・リミテッド | 抗イヌcd20抗体 |
| IL312359A (en) * | 2021-11-10 | 2024-06-01 | Trianni Inc | Transgenic mammals and methods of use thereof |
| IL314314A (en) | 2022-02-09 | 2024-09-01 | Petmedix Ltd | Therapeutic antibodies |
| GB202209247D0 (en) | 2022-06-23 | 2022-08-10 | Petmedix Ltd | Animal models and therapeutic molecules |
| GB202217993D0 (en) | 2022-11-30 | 2023-01-11 | Petmedix Ltd | Therapeutic antibodies |
| GB202217978D0 (en) | 2022-11-30 | 2023-01-11 | Petmedix Ltd | Rodents expressing a common light chain |
| EP4652197A1 (en) | 2023-01-20 | 2025-11-26 | Petmedix Ltd. | Therapeutic antibodies |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2022959C (en) * | 1989-08-10 | 2001-03-20 | Hiroaki Maeda | Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin |
| AU640397B2 (en) * | 1989-08-25 | 1993-08-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulin |
| AU8507191A (en) * | 1990-08-29 | 1992-03-30 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| AU2002359851A1 (en) * | 2001-12-21 | 2003-07-30 | Idexx Laboratories, Inc. | Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| SI1983000T1 (sl) * | 2003-11-21 | 2015-12-31 | Ucb Biopharma Sprl | Postopek za zdravljenje multiple skleroze z zaviranjem aktivnosti il-17 |
| US8722587B2 (en) * | 2008-04-09 | 2014-05-13 | The Trustees Of The University Of Pennsylvania | Single chain fragment variable antibody libraries and uses thereof |
| CN102638971B (zh) * | 2009-07-08 | 2015-10-07 | 科马布有限公司 | 动物模型及治疗分子 |
| PL3251503T3 (pl) * | 2010-03-31 | 2024-07-08 | Ablexis, Llc | Modyfikacja myszy metodami inżynierii genetycznej w celu wytworzenia przeciwciał chimerycznych |
| RU2580017C2 (ru) * | 2010-07-26 | 2016-04-10 | Трианни, Инк. | Трансгенные животные и способы применения |
| US10662256B2 (en) * | 2010-07-26 | 2020-05-26 | Trianni, Inc. | Transgenic mammals and methods of use thereof |
| GB2495083A (en) * | 2011-09-26 | 2013-04-03 | Kymab Ltd | Human VpreB and chimaeric surrogate light chains in transgenic non-human vertebrates |
| JP6629069B2 (ja) * | 2012-06-06 | 2020-01-15 | ゾエティス・エルエルシー | イヌ化抗ngf抗体およびその方法 |
| US11116795B2 (en) * | 2015-07-10 | 2021-09-14 | The Trustees Of The University Of Pennsylvania | Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor |
-
2017
- 2017-04-10 GB GB1705725.8A patent/GB2561352B/en active Active
-
2018
- 2018-04-10 DK DK18719629.0T patent/DK3609319T3/da active
- 2018-04-10 JP JP2020504455A patent/JP2020512840A/ja active Pending
- 2018-04-10 EP EP18719629.0A patent/EP3609319B1/en active Active
- 2018-04-10 FI FIEP18719629.0T patent/FI3609319T3/fi active
- 2018-04-10 PT PT187196290T patent/PT3609319T/pt unknown
- 2018-04-10 ES ES18719629T patent/ES3015425T3/es active Active
- 2018-04-10 CN CN201880038549.6A patent/CN111031789A/zh active Pending
- 2018-04-10 EP EP25155602.3A patent/EP4560012A3/en active Pending
- 2018-04-10 BR BR112019021252-3A patent/BR112019021252A2/pt unknown
- 2018-04-10 CA CA3059513A patent/CA3059513A1/en active Pending
- 2018-04-10 WO PCT/GB2018/050946 patent/WO2018189520A1/en not_active Ceased
- 2018-04-10 PL PL18719629.0T patent/PL3609319T3/pl unknown
- 2018-04-10 US US16/604,120 patent/US20200056202A1/en active Pending
-
2023
- 2023-05-10 JP JP2023078065A patent/JP2023104949A/ja active Pending
-
2025
- 2025-04-02 JP JP2025061261A patent/JP2025107178A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI3609319T3 (fi) | 2025-03-27 |
| JP2023104949A (ja) | 2023-07-28 |
| EP3609319B1 (en) | 2025-02-26 |
| GB2561352B (en) | 2023-01-18 |
| US20200056202A1 (en) | 2020-02-20 |
| CA3059513A1 (en) | 2018-10-18 |
| EP4560012A2 (en) | 2025-05-28 |
| EP3609319A1 (en) | 2020-02-19 |
| JP2025107178A (ja) | 2025-07-17 |
| WO2018189520A1 (en) | 2018-10-18 |
| EP4560012A3 (en) | 2025-07-30 |
| ES3015425T3 (en) | 2025-05-05 |
| PL3609319T3 (pl) | 2025-06-02 |
| GB2561352A (en) | 2018-10-17 |
| CN111031789A (zh) | 2020-04-17 |
| GB201705725D0 (en) | 2017-05-24 |
| JP2020512840A (ja) | 2020-04-30 |
| PT3609319T (pt) | 2025-03-27 |
| BR112019021252A2 (pt) | 2020-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3609319T3 (pl) | Modele mysie i cząsteczki terapeutyczne | |
| DK3601367T3 (da) | Kimære molekyler og anvendelse deraf | |
| EP3673947A4 (en) | CATHETER AND CATHETER KIT | |
| DK3283106T3 (da) | Terapeutiske antistoffer og anvendelser deraf | |
| DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| EP3496074A4 (en) | MEDICAL SIMULATOR | |
| DK3529257T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| EP3645118C0 (en) | SIMULATION-BASED DRUG TREATMENT PLANNING | |
| DK4105223T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| DK3516160T3 (da) | Brøndanordning og tilhørende fremgangsmåder | |
| DK3365368T3 (da) | Tgfbeta1-bindende immunoglobuliner og anvendelse deraf | |
| DK3828194T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| EP3440659A4 (en) | CARDIOPULMONARY RESUSCITATION TRAINING SYSTEM AND METHOD | |
| DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
| DK3294770T3 (da) | Terapeutiske og diagnostiske fremgangsmåder til cancer | |
| DK3210977T3 (da) | Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf | |
| DK3511019T3 (da) | Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf | |
| EP3794941C0 (en) | ANIMAL MODELS AND THERAPEUTIC MOLECULES | |
| DK3319612T3 (da) | Oxysteroler og fremgansmåder til anvendelse derfor | |
| DK3368655T3 (da) | Forbedret proteinekspression og fremgangsmåder dertil | |
| GB201816442D0 (en) | Animal models and therapeutic molecules | |
| DK3481581T3 (da) | Metalwiretilførselssystem og fremgangsmåde | |
| EP3961945C0 (en) | DECODING METHODS AND APPARATUS |